Detalhe da pesquisa
1.
Tumor necrosis factor-mediated disposition of infliximab in ulcerative colitis patients.
J Pharmacokinet Pharmacodyn
; 46(6): 543-551, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31489538
2.
Commensal-Specific CD4(+) Cells From Patients With Crohn's Disease Have a T-Helper 17 Inflammatory Profile.
Gastroenterology
; 151(3): 489-500.e3, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27267052
3.
Evolution of cytokines and inflammatory biomarkers during infliximab induction therapy and the impact of inflammatory burden on primary response in patients with Crohn's disease.
Scand J Gastroenterol
; 52(10): 1086-1092, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28622097
4.
The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS study.
Gut
; 65(2): 249-55, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25670812
5.
Antibodies to adalimumab are associated with future inflammation in Crohn's patients receiving maintenance adalimumab therapy: a post hoc analysis of the Karmiris trial.
Gut
; 65(7): 1126-31, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25862647
6.
Pharmacokinetic Features and Presence of Antidrug Antibodies Associate With Response to Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis.
Clin Gastroenterol Hepatol
; 14(2): 251-8.e1-2, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26545802
7.
The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease.
Gut
; 64(10): 1539-45, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25336114
8.
Long-term outcome of patients with Crohn's disease who discontinued infliximab therapy upon clinical remission.
Clin Gastroenterol Hepatol
; 13(6): 1103-10, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25478919
9.
Concentrations of 6-thioguanine nucleotide correlate with trough levels of infliximab in patients with inflammatory bowel disease on combination therapy.
Clin Gastroenterol Hepatol
; 13(6): 1118-24.e3, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25562796
10.
Early trough levels and antibodies to infliximab predict safety and success of reinitiation of infliximab therapy.
Clin Gastroenterol Hepatol
; 12(9): 1474-81.e2; quiz e91, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24486408
11.
Antibody response to infliximab and its impact on pharmacokinetics can be transient.
Am J Gastroenterol
; 108(6): 962-71, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23419382
12.
Serum and colonic mucosal immune markers in irritable bowel syndrome.
Am J Gastroenterol
; 107(2): 262-72, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22158028
13.
PI3K independent activation of mTORC1 as a target in lapatinib-resistant ERBB2+ breast cancer cells.
Breast Cancer Res Treat
; 136(3): 683-92, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23089982
14.
Highly sensitive proximity mediated immunoassay reveals HER2 status conversion in the circulating tumor cells of metastatic breast cancer patients.
Proteome Sci
; 9(1): 75, 2011 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22172159
15.
Immunogenicity to infliximab is associated with HLA-DRB1.
Gut
; 64(8): 1344-5, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25876612
16.
Current Trends in IBD-Development of Mucosal-Based Biomarkers and a Novel Minimally Invasive Recoverable Sampling System.
Inflamm Bowel Dis
; 27(Suppl 2): S17-S24, 2021 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34791290
17.
A novel class of polymeric fluorescent dyes assembled using a DNA synthesizer.
PLoS One
; 15(12): e0243218, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33275644
18.
An in vivo platform for translational drug development in pancreatic cancer.
Clin Cancer Res
; 12(15): 4652-61, 2006 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16899615
19.
Feedback activation of HER3 attenuates response to EGFR inhibitors in colon cancer cells.
Oncotarget
; 8(3): 4277-4288, 2017 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-28032592
20.
A clinically feasible multiplex proteomic immunoassay as a novel functional diagnostic for pancreatic ductal adenocarcinoma.
Oncotarget
; 8(15): 24250-24261, 2017 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28445954